Fig. 3.
Global distribution of the two most used artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated falciparum malaria in 2018, especially artemether-lumefantine and artesunate-amodiaquine, the most deployed ACT in malaria endemic countries. The figure was generated by compiling the data obtained by WHO in 2018 [117].
